hVIVO plc (LON:HVO – Get Free Report) shot up 10.5% during trading on Monday . The stock traded as high as GBX 22 ($0.27) and last traded at GBX 21.35 ($0.27). 6,501,964 shares changed hands during trading, an increase of 125% from the average session volume of 2,888,891 shares. The stock had previously closed at GBX 19.33 ($0.24).
hVIVO Stock Performance
The company has a market capitalization of £145.26 million, a PE ratio of 711.67 and a beta of 0.97. The stock’s 50-day simple moving average is GBX 20.36 and its 200 day simple moving average is GBX 25.73. The company has a debt-to-equity ratio of 33.86, a quick ratio of 1.16 and a current ratio of 1.61.
hVIVO Company Profile
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- What is an Earnings Surprise?
- New Year, New Buybacks: 3 Big-Name Stocks Planning Repurchases
- Profitably Trade Stocks at 52-Week Highs
- Why These 3 Stocks With High Call Option Volume Deserve Attention
- Market Cap Calculator: How to Calculate Market Cap
- D-Wave: Recent Updates Propel Shares Off 2025 Lows
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
